Health Care/Hospital
First patient enrollment in the U.S. - A milestone for the global multi-center phase Ⅲ clinical trial of telitacicept for myasthenia gravis
YANTAI, China, Aug. 6, 2024 /PRNewswire/ -- RemeGen Co. Ltd.
2024-08-06 17:00
2038
Ping An Ranked in the Fortune Global 500 for the 15th Consecutive Year
HONG KONG and SHANGHAI, Aug. 6, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. ("Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) is 53rd on the Fortune 500 list for 2024. With revenue of USD14.58 billion, the Group ranked 9th among global financial e...
2024-08-06 15:10
3495
First Patient Enrolled in the US Phase 2 Combination Therapy of Akeso's Ligufalimab with Azacitidine for Myelodysplastic Syndrome
HONG KONG, Aug. 6, 2024 /PRNewswire/ -- Akeso has announced the completion of the first patient enrollment in the US for the phase II clinical trial of its innovative CD47 monoclonal antibody, ligufalimab (AK117), in combination with azacitidine for patients with newly diagnosed higher-risk myelo...
2024-08-06 12:44
1655
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics
SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion-dependent β-thalassemia. Utilizing their pioneering transformer Base Editor (tBE), Correctseq has successfull...
2024-08-06 11:01
1772
Terumo Establishes Corporate Venture Capital "Terumo Ventures"
TOKYO, Aug. 6, 2024 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced that it has established "Terumo Ventures," a Corporate Venture Capital (CVC) organization responsible for leading the Group's venture investments, as a department within Terumo Americas Holding, Inc. Terumo Vent...
2024-08-06 09:00
2581
VISTA Eye Specialist Launches Corporate Program to Combat Rising Workplace Eye Issues
PETALING JAYA, Malaysia, Aug. 6, 2024 /PRNewswire/ -- VISTA Eye Specialist ("VISTA"), a leading provider of eye care services, today announced the launch of its Premier Corporate Partner Program. This initiative aims to combat the rising incidence of eye diseases, including dry eye caused by prol...
2024-08-06 08:00
1717
Antengene Announces XPOVIO® (selinexor) Approved for Commercialization in Malaysia
* XPOVIO® is the first and only approved XPO1 inhibitor in Malaysia. * XPOVIO® has been approved for multiple indications in eight markets across the APAC region. Antengene has submitted new drug applications (NDAs) for XPOVIO ® in other ASEAN markets including Thailand and Indonesia with app...
2024-08-06 08:00
1805
Everest Medicines to Announce 2024 Interim Results on August 28, 2024
SHANGHAI, Aug. 6, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim result...
2024-08-06 07:30
2911
META Pharmaceuticals announces FDA Grants Rare Pediatric Disease Designation to META-001-PH for the Treatment of Primary Hyperoxaluria
HONG KONG, Aug. 5, 2024 /PRNewswire/ -- META Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its investigational new drug META-001-PH for the treatment of primary hyperoxaluria (PH).Primary hyperoxaluria is a...
2024-08-05 21:52
1895
Shanton Reaches Full Enrollment in Phase 2b Refractory/Tophaceous Gout Study with SAP-001
SAP-001 is Shanton's lead investigational compound with Best-in-Class potential in uncontrolled gout PRINCETON, N.J., Aug. 5, 2024 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a groundbreaking treatment for refractory and tophaceous gout patients, today announced f...
2024-08-05 21:00
1551
Everise Honored at Stevie® Awards for Great Employers With Multiple Wins
PLANTATION, Fla., Aug. 5, 2024 /PRNewswire/ -- Everise has been named winner in several categories in the annual Stevie Awards for Great Employers, which recognize the world's best employers and teams who help to create and drive great places to work. Everise was awarded with Gold and Silver wins...
2024-08-05 21:00
18764
Seegene Showcased its Multiplex Technology at ADLM 2024
- Exhibited multiplex PCR testing technologies that provide comprehensive results from a single test - Presented high-multiplex assays and automated testing systems - Introduced the SG OneSystem™ business, the company's global technology-sharing initiative SEOUL, South Korea, Aug. 5, 2024 /P...
2024-08-05 21:00
2162
PENTAX Medical Receives FDA Clearance for Duodenoscope with New Sterilization Technology in Collaboration with Advanced Sterilization Products.
TOKYO, Aug. 5, 2024 /PRNewswire/ -- PENTAX Medical, a division of HOYA group, proudly announces FDA clearance of the DEC™ Duodenoscope (ED34-i10T2s) compatibility with the STERRAD™ 100NX Sterilizer, the flagship product from Advanced Sterilization Products (ASP), a division of Fortive. The colla...
2024-08-05 20:00
2160
Antennova Announces CD73 Small Molecule Inhibitor Accepted for Mini Oral Presentation at ESMO Congress 2024
BOSTON, Aug. 5, 2024 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced that the orally administered CD73 small molecule inhibitor ATN-037(also known as ATG-037) has been accepted for Mini Oral presentation at the 2024 European Society of Medical Oncol...
2024-08-05 20:00
1584
QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER
* Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Pharmaceuticals. * Mr Doyle brings extensive knowledg...
2024-08-05 19:00
1938
So-Young to Report Second Quarter 2024 Financial Results on August 23, 2024
BEIJING, Aug. 5, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financ...
2024-08-05 17:00
2548
Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery
TAIPEI, Aug. 5, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (" Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights inCanada to the commercialization of clobetasol propionate ophthalmi...
2024-08-05 16:30
1675
Siriraj Hospital Integrates AI to Elevate Medical Research and Diagnosis, Touts YOLO Model for Centroblast Cell Counting
BANGKOK, Aug. 5, 2024 /PRNewswire/ -- The Faculty of Medicine Siriraj Hospital at Mahidol University has announced the integration of artificial intelligence (AI) technology to improve medical analysis and diagnostic capabilities. This initiative aims to enhance accuracy in detecting abnormalitie...
2024-08-05 11:53
1804
HGC wins "Community Education and Engagement Award" at NEXX Sustainability & ESG Awards 2024
Fulfils Corporate Social Responsibility Realises Sustainable Development HONG KONG, Aug. 5, 2024 /PRNewswire/ -- HGC Global Communications ("HGC" or "Group"), a fully-fledged ICT service provider and network operator with extensive global coverage, has won the " Community Education and Engagem...
2024-08-05 10:59
1902
DKSH and Kyowa Kirin Forge Strategic Partnership Across Asia-Pacific
DKSH has signed a strategic business partnership with Kyowa Kirin, a Japan -based global specialty pharmaceutical company, to provide comprehensive services for their specialty drugs in South Korea, Taiwan region, Singapore, Thailand, Malaysia and Hong Kong & Macau SAR. With DKSH's expertise, dis...
2024-08-05 10:34
16628
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6217
